Jonathan D. Glass

Jonathan D. Glass

Neuromusculoskeletal Medicine

12 Executive Park Drive Northeast
Atlanta, GA 30329

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 194 publications

ALSUntangled #84 - ivermectin.

ALSUntangled #84 - ivermectin.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: August 06, 2026

Cutaneous Mycobacterium llatzerense in an immunocompetent woman: Case report and literature review.

Cutaneous Mycobacterium llatzerense in an immunocompetent woman: Case report and literature review.

Journal: JAAD case reports

Published: April 30, 2026

Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage population.

Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage population.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: April 13, 2026

ALS untangled #83: clenbuterol.

ALS untangled #83: clenbuterol.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 08, 2026

Wild-type C9orf72 expression is a genetic modifier of C9-ALS survival.

Wild-type C9orf72 expression is a genetic modifier of C9-ALS survival.

Journal: medRxiv : the preprint server for health sciences

Published: February 23, 2026

Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis.

Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis.

Journal: JAMA neurology

Published: February 09, 2026

Fast and slow strains of misfolded mutant superoxide dismutase 1 in familial amyotrophic lateral sclerosis.

Fast and slow strains of misfolded mutant superoxide dismutase 1 in familial amyotrophic lateral sclerosis.

Journal: Acta neuropathologica communications

Published: November 07, 2025

ALSUntangled #81: Pyridostigmine (mestinon®).

ALSUntangled #81: Pyridostigmine (mestinon®).

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: November 06, 2025

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis.

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis.

Journal: Nature genetics

Published: August 15, 2025

Subtyping based on hippocampal cryptic exon burden reveals proteome-wide changes associated with TDP-43 and Alzheimer's disease pathology.

Subtyping based on hippocampal cryptic exon burden reveals proteome-wide changes associated with TDP-43 and Alzheimer's disease pathology.

Journal: Cell reports

Published: August 07, 2025

TDP-43 toxic gain of function links ALS, FTD and Alzheimer's Disease through splicing dysregulation.

TDP-43 toxic gain of function links ALS, FTD and Alzheimer's Disease through splicing dysregulation.

Journal: bioRxiv : the preprint server for biology

Published: July 14, 2025

Molecular subtyping based on hippocampal cryptic exon burden reveals proteome-wide changes associated with TDP-43 pathology across the spectrum of LATE and Alzheimer's Disease.

Molecular subtyping based on hippocampal cryptic exon burden reveals proteome-wide changes associated with TDP-43 pathology across the spectrum of LATE and Alzheimer's Disease.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

Showing 1-12 of 194

Last Updated: 09/26/2026